9 Results

People

  1. De Angelis
    De Angelis
  2. Karimi
    Karimi
  3. Abrey
    Abrey
  4. Panageas
    Panageas
  5. Hormigo
    Hormigo
  6. Lassman
    Lassman
  7. Fleisher
    Fleisher
  8. Holland
    Holland
  9. Stubblefield
    Stubblefield
  10. Dantis
    Dantis

Groups

  1. Neuroradiology Service (9)
  2. Radiology, Department of (9)
  3. Tow Center for Developmental Oncology (TCDO) (9)
  4. Biostatistics Service (7)
  5. Epidemiology and Biostatistics (7)
  6. Population Sciences Research Program (7)
  7. Surgery (4)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  9. Critical Care Center Leadership (1)
  10. Critical Care Center (1)
  1. "adult"
  2. "Lisa De Angelis"
  3. "Sasan Karimi"
Formats
  1. Journal Article (9)
Groups
  1. Neuroradiology Service (9)
  2. Radiology, Department of (9)
  3. Tow Center for Developmental Oncology (TCDO) (9)
  4. Biostatistics Service (7)
  5. Epidemiology and Biostatistics (7)
  6. Population Sciences Research Program (7)

More Groups

People
  1. Lisa De Angelis (9)
  2. Sasan Karimi (9)
  3. Katherine Panageas (7)
  4. Lauren Abrey (7)
  5. Adilia Hormigo (6)
  6. Andrew Lassman (6)

More People

Years
  1. 2014 (2)
  2. 2013 (1)
  3. 2011 (3)
  4. 2009 (1)
  5. 2008 (1)
  6. 2006 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Journal of Clinical Oncology (2)
  3. Neuro-Oncology (2)
  4. Annals of Neurology (1)
  5. Journal of Neuro-Oncology (1)
  6. Neurology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Oxford University Press (2)
  4. Lippincott Williams & Wilkins (1)
  5. Springer (1)
  6. Wiley Blackwell (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
    Journal Article

    Kaley, T. J.; Wen, P.; Schiff, D.; Ligon, K.; Haidar, S.; Karimi, S.; Lassman, A. B.; Nolan, C. P.; De Angelis, L. M.; Gavrilovic, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
    Journal Article

    Morris, P. G.; Correa, D. D.; Yahalom, J.; Raizer, J. J.; Schiff, D.; Grant, B.; Grimm, S.; Lai, R. K.; Reiner, A. S.; Panageas, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Journal of Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
    Journal Article

    Hottinger, A. F.; Iwamoto, F. M.; Karimi, S.; Riedel, E.; Dantis, J.; Park, J.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Annals of Neurology (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Ischemic stroke in patients with primary brain tumors
    Journal Article

    Kreisl, T. N.; Toothaker, T.; Karimi, S.; Deangelis, L. M.
    Neurology (2008)

    Fulltext@MSK | Save
  • YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
    Journal Article

    Hormigo, A.; Gu, B.; Karimi, S.; Riedel, E.; Panageas, K. S.; Edgar, M. A.; Tanwar, M. K.; Rao, J. S.; Fleisher, M.; Deangelis, L. M.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save